To use PrepaCyte for cell separation, researchers treat the cells, from human bone marrow, umbilical cord blood, or peripheral blood, with an anticoagulant and then mix the cells and PrepaCyte in a ...
BioE®, Inc., has announced it submitted a 510(k) pre-market notification application to the U.S. Food and Drug Administration (FDA) requesting regulatory and marketing clearance for its PrepaCyte®-CB ...
BioE ®, Inc. and the University of Newcastle upon Tyne in England have announced the two parties have formed a research partnership to advance the near-term therapeutic application of cells derived ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback